Objectives

After participating in this educational activity, attendees should be able to:

1. Identify contraindications for therapy with 4 factor prothrombin complex concentrate
2. Describe key points published within current literature to support recommendations for DOAC or warfarin reversal
3. Construct a treatment plan for DOAC or warfarin reversal in patients presenting with a major bleed

Faculty

Jennifer Hammond, PharmD
PGY2 Emergency Medicine Pharmacy Resident
Pharmacist
Baystate Medical Center 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

None of the other planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Accreditation Statement
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.